You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Zanubrutinib for treating relapsed or refractory mantle cell lymphoma

  • Technology appraisal guidance
  • Reference number: TA1081
  • Published:  10 July 2025
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

NIHRIO BN: 37640-Zanubrutinib-for-Mantle-Cell-Lymphoma-V1.0-NOV2023-NON-CONF.pdf (nihr.ac.uk)

This page was last updated: 21 December 2023

Back to top